Did you lose money in LNTH? Shareholders Who Incurred Significant Losses in Lantheus Holdings, Inc. Should Contact Robbins LLP for Information
Lantheus Holdings(US:LNTH) Prnewswire·2025-09-19 22:33Accessibility StatementSkip Navigation SAN DIEGO, Sept. 19, 2025 /PRNewswire/ -- Robbins LLPÂ reminds stockholders that a class action was filed on behalf of persons and entities that purchased or otherwise acquired Lantheus Holdings, Inc. (NASAQ: LNTH) securities between February 26, 2025 and August 5, 2025. Lantheus is a global company that develops, manufactures, sells, and distributes certain diagnostic and therapeutic products. The Company's key Radiopharmaceutical Oncology product is Pylarify, a PET i ...